Aspire-Lakewood Holdings, Inc. (ASBP) earnings
ASBP earnings moved a median of -0.56% by the close. Quarterly and annual ASBP reports and results, each read against the price at its own news timestamp. Back to the ASBP overview →
10 measured ASBP earnings events.
Where these ASBP earnings landedvs 10 measured ASBP earnings reactions
| Middle 50% of ASBP earnings reactions | -5.60% to +8.33% |
|---|---|
| Median reaction (to close) | -0.56% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 ASBP earnings events with a measured close landed between -5.60% and +8.33%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Aspire Biopharma Holding For: Jun 30 | SEC filing · Form 10-Q | — | +10.25% | |
| Form 10-Q Aspire Biopharma Holding For: Mar 31 | SEC filing · Form 10-Q | +3.36% | +18.02% | |
| Form 10-K/A Aspire Biopharma Holding For: Dec 31 | SEC filing · Form 10-K | -1.71% | +2.56% | |
| Form 10-K Aspire Biopharma Holding For: Dec 31 | SEC filing · Form 10-K | -1.99% | +10.34% | |
| Form 10-Q Aspire Biopharma Holding For: Sep 30 | SEC filing · Form 10-Q | -4.83% | -29.60% | |
| Form 10-Q/A Aspire Biopharma Holding For: Sep 30 | SEC filing · Form 10-Q | -3.04% | -10.49% | |
| Form 10-Q Aspire Biopharma Holding For: Jun 30 | SEC filing · Form 10-Q | -3.41% | -1.64% | |
| Form 10-Q/A Aspire Biopharma Holding For: Mar 31 | SEC filing · Form 10-Q | -3.41% | -1.64% | |
| Form 10-Q Aspire Biopharma Holding For: Mar 31 | SEC filing · Form 10-Q | +5.29% | +0.52% | |
| Form 10-K Aspire Biopharma Holding For: Dec 31 | SEC filing · Form 10-K | +2.09% | -6.91% |
Keep exploring
More ASBP: analyst actions → · SEC filings → · ASBP overview →